CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 48 filers reported holding CHEMBIO DIAGNOSTICS INC in Q3 2021. The put-call ratio across all filers is 2.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $11,000 | -88.2% | 17,361 | -84.7% | 0.00% | -100.0% |
| Q1 2022 | $93,000 | -39.6% | 113,368 | -16.2% | 0.00% | -42.9% |
| Q4 2021 | $154,000 | +63.8% | 135,235 | +326.2% | 0.01% | +16.7% |
| Q2 2021 | $94,000 | -25.4% | 31,730 | -11.3% | 0.01% | 0.0% |
| Q1 2021 | $126,000 | -28.4% | 35,763 | -33.9% | 0.01% | -33.3% |
| Q2 2020 | $176,000 | – | 54,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Penbrook Management LLC | 344,060 | $1,634,000 | 1.26% |
| Union Square Park Capital Management, LLC | 400,000 | $1,900,000 | 0.76% |
| P.A.W. CAPITAL CORP | 100,000 | $475,000 | 0.42% |
| PRECEPT MANAGEMENT LLC | 150,000 | $713,000 | 0.29% |
| Newbridge Financial Services Group, Inc. | 73,500 | $349,000 | 0.29% |
| SANDERS MORRIS HARRIS LLC | 183,584 | $990,000 | 0.22% |
| FRIESS ASSOCIATES LLC | 555,000 | $2,636,000 | 0.19% |
| PERRITT CAPITAL MANAGEMENT INC | 30,651 | $146,000 | 0.09% |
| Ikarian Capital, LLC | 219,109 | $1,041,000 | 0.05% |
| SEGALL BRYANT & HAMILL, LLC | 705,823 | $3,352,000 | 0.04% |